TCM

Tamarack Capital Management Portfolio holdings

AUM $503M
1-Year Est. Return 19.47%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+19.47%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$592M
AUM Growth
+$57.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$25.6M
2
+$24.2M
3
+$22.2M
4
LNTH icon
Lantheus
LNTH
+$11.3M
5
BRKR icon
Bruker
BRKR
+$10.1M

Top Sells

1
+$24.9M
2
+$18.2M
3
+$14M
4
PFE icon
Pfizer
PFE
+$13.6M
5
KERX
Keryx Biopharmaceuticals Inc
KERX
+$12.1M

Sector Composition

1 Healthcare 83.72%
2 Technology 2.83%
3 Industrials 0.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HMSY
26
DELISTED
HMS Holdings Corp.
HMSY
$5.65M 0.96%
+329,246
CERS icon
27
Cerus
CERS
$357M
$4.49M 0.76%
+865,170
INGN icon
28
Inogen
INGN
$171M
$3.35M 0.57%
75,000
-475,000
STRM
29
DELISTED
Streamline Health Solutions
STRM
$3.19M 0.54%
75,867
SUPN icon
30
Supernus Pharmaceuticals
SUPN
$3.2B
$2.55M 0.43%
+150,000
DXCM icon
31
DexCom
DXCM
$26.1B
– –
-900,000
WINT
32
DELISTED
Windtree Therapeutics Inc
WINT
– –
-16,824
FEIC
33
DELISTED
FEI COMPANY
FEIC
– –
-35,180
IWM icon
34
iShares Russell 2000 ETF
IWM
$72.2B
– –
0
PFE icon
35
Pfizer
PFE
$154B
– –
-412,323
RMD icon
36
ResMed
RMD
$36.1B
– –
0
SPY icon
37
State Street SPDR S&P 500 ETF Trust
SPY
$682B
– –
0
TEVA icon
38
Teva Pharmaceuticals
TEVA
$36.9B
– –
-400,000
TMO icon
39
Thermo Fisher Scientific
TMO
$187B
– –
-50,000
HNGR
40
DELISTED
Hanger Inc.
HNGR
– –
-100,000
KERX
41
DELISTED
Keryx Biopharmaceuticals Inc
KERX
– –
-950,000
OREX
42
DELISTED
Orexigen Therapeutics, Inc.
OREX
– –
-100,000
STE icon
43
Steris
STE
$22B
– –
-10,000
1
2